Magentus acquires Labflow to expand pathology platform and accelerate connected care

Magentus, a leading provider of intelligent healthcare technology has announced the acquisition of Labflow, a modern, cloud-native suite of modular pathology products, in a move the company says will expands its global footprint and strengthen its position as a leader in connected, scalable healthcare solutions.

The acquisition brings together Evolution vLab, Magentus’s trusted enterprise-grade Laboratory Information Management System (LIMS), with Labflow’s innovative pathology-centric suite of software solutions. This step creates a unified pathology ecosystem that supports high-volume networks, smaller labs, and emerging markets across Australia, New Zealand, the UK, and South and Southeast Asia.

“This is a pivotal moment for Magentus and for pathology providers globally,” said Martin Hayden, Chief Strategy Officer at Magentus.

“Labflow’s modular innovation and proven interoperability unlock new opportunities for us to serve a broader spectrum of labs, from national networks to smaller agile providers, while accelerating our mission to deliver smarter, safer, and more connected care.”

Deployment across APAC and beyond

Labflow’s platforms are already deployed across Australia and India, with deployments underway in Malaysia and Singapore. According to Magentus, Labflow’s flexible architecture will allow the combined business to enter new markets faster, and offer tailored solutions that meet local needs and scale with demand.

“Joining Magentus allows us to amplify our impact,” said Ben Richardson, CEO of Labflow.

“Together, we’re building a modular, future-ready pathology platform that combines speed, configurability, and clinical insight, helping labs embrace the future to deliver faster results, reduce admin burden, and improve patient outcomes.”

Focus on workflow, interoperability and compliance

Magentus highlights several key benefits for users of the combined platform:

• Smarter workflows: Intelligent automation and AI-readiness built into core operations
• Modular flexibility: Scalable solutions for both enterprise and point-of-care needs
• Seamless interoperability: Vendor-neutral integration across analysers, EMRs, and third-party tools
• Global reach: Proven deployments across APAC and EMEA, with further expansion underway
• Secure and compliant: Built for national standards, privacy, and resilience

Magentus says the acquisition reinforces its commitment to creating a healthier society through connected care, and positions the company to lead the next wave of digital transformation in pathology.